Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deep whole-genome analysis of 494 hepatocellular carcinomas
Lei Chen, Chong Zhang, Ruidong Xue, et al.
Nature (2024) Vol. 627, Iss. 8004, pp. 586-593
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Modern biology of extrachromosomal DNA: A decade-long voyage of discovery
Qinglin Yang, Yulei Xie, Kailiang Qiao, et al.
Cell Research (2025) Vol. 35, Iss. 1, pp. 11-22
Open Access | Times Cited: 3
Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges
Shunzhen Zheng, Siew Wee Chan, Fei Liu, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1582-1582
Open Access | Times Cited: 11
Hepatitis Delta Virus and Hepatocellular Carcinoma
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 8
Should AI-Powered Whole-Genome Sequencing Be Used Routinely for Personalized Decision Support in Surgical Oncology—A Scoping Review
Kokiladevi Alagarswamy, Wenjie Shi, Aishwarya Boini, et al.
BioMedInformatics (2024) Vol. 4, Iss. 3, pp. 1757-1772
Open Access | Times Cited: 5
Fibrinogen and tumors
Xinyuan Wu, Xiaomin Yu, Cheng Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Investigating the origins of the mutational signatures in cancer
Gunnar Boysen, Ludmil B. Alexandrov, Raheleh Rahbari, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 1
Open Access
An expanding universe of mutational signatures and its rapid evolution in single-stranded RNA viruses
Yue Yang, Xinyi Zhang, Tingting Chen, et al.
Molecular Biology and Evolution (2025)
Open Access
Sorafenib as Adjuvant Therapy Post–Liver Transplant: A Single-center Experience
Hala Hassanain, Ashton A. Connor, Elizabeth W. Brombosz, et al.
Transplantation Direct (2025) Vol. 11, Iss. 2, pp. e1746-e1746
Open Access
Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment
Jiarui Lv, Yanan Wang, Jiacheng Lv, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Myeloid cell path to malignancy: insights into liver cancer
Christel Ramirez, Leila Akkari
Trends in cancer (2025)
Open Access
Halting hepatocellular carcinoma: Identifying intercellular crosstalk in HBV-driven disease
Lingyun Zhou, Chang‐Hai Liu, Duoduo Lv, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115457-115457
Open Access
An Investigative Study of LGALSL and HLA‐DRB1 as Prognostic Biomarkers and Therapeutic Targets in Chronic Hepatitis B Patients With Persistent HBV DNA Viremia Under Entecavir Treatment
Qun Wan, Xiaolin Yu, Jinyu Huang, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 4
Closed Access
Lactic acid: a narrative review of a promoter of the liver cancer microenvironment
Junhe Chen, Guifang He, Duo Cai, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 3, pp. 1282-1296
Open Access | Times Cited: 3
Genomic and transcriptomic analyses of chemical hepatocarcinogenesis aggravated by oncoprotein loss
Xinyi Wang, Yingluo Liu, Shuo Zhang, et al.
Hepatology (2024)
Closed Access | Times Cited: 3
Liver Cancer Etiology: Old Issues and New Perspectives
Jianguo Chen, Yong-Hui Zhang, Jianhua Lu, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1452-1468
Closed Access | Times Cited: 3
Multi-omic profiling reveals potential biomarkers of hepatocellular carcinoma prognosis and therapy response among mitochondria-associated cell death genes in the context of 3P medicine
Dingtao Hu, Xu Shen, Peng Fei Gao, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 321-343
Closed Access | Times Cited: 2
Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix
Baoyue Pan, Shumei Yan, Linjing Yuan, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 3, pp. 372-385
Open Access | Times Cited: 2
AmpliconSuite: an end-to-end workflow for analyzing focal amplifications in cancer genomes
Jens Luebeck, E.-S. Huang, Forrest Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches
Veronica Porreca, Cristina Barbagallo, Eleonora Corbella, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2889-2889
Open Access | Times Cited: 2
FGA influences invasion and metastasis of hepatocellular carcinoma through the PI3K/AKT pathway
Xi Han, Zefeng Liu, Mengying Cui, et al.
Aging (2024)
Open Access | Times Cited: 2
Plasma cell-free DNA methylomes for hepatocellular carcinoma detection and monitoring after liver resection or transplantation
K Chen, Zhihao Li, Bianca O. Kirsh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Prognostic and Immunotherapeutic Predictive Value of CAD Gene in Hepatocellular Carcinoma: Integrated Bioinformatics and Experimental Analysis
Xu Wang, Jin-Kai Feng, Feifei Mao, et al.
Molecular Biotechnology (2024) Vol. 67, Iss. 3, pp. 1240-1255
Closed Access | Times Cited: 1
Integrated machine learning screened glutamine metabolism-associated biomarker SLC1A5 to predict immunotherapy response in hepatocellular carcinoma
Guixiong Zhang, Yitai Xiao, Hang Liu, et al.
Immunobiology (2024) Vol. 229, Iss. 5, pp. 152841-152841
Open Access | Times Cited: 1
New advances in the treatment of intermediate and advanced hepatocellular carcinoma
Zhonghao Jiang, Fan Yang
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top